{"transactions":[{"id":677560,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-24T21:00:07.000Z","date":"2026-08-24","kind":"purchase","planned":false,"acquired":true,"shares":11000,"price":4.3392,"value":47731.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.3097 to $4.3489 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 542,784 restricted stock units."}],"balance_after":7404383,"source":{"system":"sec-edgar","filing":"0001193125-26-363737","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526363737/ownership.xml","form_type":"4"}},{"id":677559,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-24T21:00:07.000Z","date":"2026-08-21","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":4.3495,"value":21747.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 542,784 restricted stock units."}],"balance_after":7393383,"source":{"system":"sec-edgar","filing":"0001193125-26-363737","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526363737/ownership.xml","form_type":"4"}},{"id":677558,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-24T21:00:07.000Z","date":"2026-08-20","kind":"purchase","planned":false,"acquired":true,"shares":39944,"price":4.4356,"value":177175.6064,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.3198 to $4.5048 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 542,784 restricted stock units."}],"balance_after":7388383,"source":{"system":"sec-edgar","filing":"0001193125-26-363737","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526363737/ownership.xml","form_type":"4"}},{"id":740126,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-12T13:26:46.000Z","date":"2026-06-11","kind":"purchase","planned":false,"acquired":true,"shares":9891,"price":4.0423,"value":39982.3893,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The original Form 4, filed on June 11, 2026, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a purchase that occurred on June 11, 2026 as a total of 22,887 shares purchased when in fact 9,891 shares of the Issuer's common stock were purchased."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $3.9600 to $4.1700 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 542,784 restricted stock units."}],"balance_after":7348439,"source":{"system":"sec-edgar","filing":"0001193125-26-268606","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526268606/ownership.xml","form_type":"4/A","original_submission_date":"2026-06-11"}},{"id":740125,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-12T13:26:46.000Z","date":"2026-06-10","kind":"purchase","planned":false,"acquired":true,"shares":14715,"price":4.024,"value":59213.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The original Form 4, filed on June 11, 2026, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a purchase that occurred on June 10, 2026 as a total of 29,430 shares purchased when in fact 14,715 shares of the Issuer's common stock were purchased."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $3.9300 to $4.1000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 542,784 restricted stock units."}],"balance_after":7338548,"source":{"system":"sec-edgar","filing":"0001193125-26-268606","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526268606/ownership.xml","form_type":"4/A","original_submission_date":"2026-06-11"}},{"id":741848,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-11T20:52:42.000Z","date":"2026-06-11","kind":"purchase","planned":false,"acquired":true,"shares":22887,"price":4.0434,"value":92541.2958,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $3.9600 to $4.1700 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 542,784 restricted stock units."}],"balance_after":7376150,"source":{"system":"sec-edgar","filing":"0001193125-26-267800","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526267800/ownership.xml","form_type":"4"}},{"id":741847,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-11T20:52:42.000Z","date":"2026-06-10","kind":"purchase","planned":false,"acquired":true,"shares":29430,"price":4.024,"value":118426.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $3.9300 to $4.1000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 542,784 restricted stock units."}],"balance_after":7353263,"source":{"system":"sec-edgar","filing":"0001193125-26-267800","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526267800/ownership.xml","form_type":"4"}},{"id":757192,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-01T20:38:10.000Z","date":"2026-06-01","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":3.5583,"value":177915.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $3.5100 to $3.6000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 542,784 restricted stock units."}],"balance_after":7323833,"source":{"system":"sec-edgar","filing":"0001193125-26-251587","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526251587/ownership.xml","form_type":"4"}},{"id":760331,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-28T20:33:12.000Z","date":"2026-05-28","kind":"purchase","planned":false,"acquired":true,"shares":61202,"price":3.0199,"value":184823.9198,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $2.8233 to $3.1150 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 542,784 restricted stock units."}],"balance_after":7273833,"source":{"system":"sec-edgar","filing":"0001193125-26-245341","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526245341/ownership.xml","form_type":"4"}},{"id":760330,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-28T20:33:12.000Z","date":"2026-05-27","kind":"purchase","planned":false,"acquired":true,"shares":49810,"price":2.8747,"value":143188.807,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $2.7976 to $2.9400 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 542,784 restricted stock units."}],"balance_after":7212631,"source":{"system":"sec-edgar","filing":"0001193125-26-245341","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526245341/ownership.xml","form_type":"4"}},{"id":760329,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-28T20:33:12.000Z","date":"2026-05-26","kind":"purchase","planned":false,"acquired":true,"shares":4508,"price":2.7897,"value":12575.9676,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $2.7600 to $2.8000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 542,784 restricted stock units."}],"balance_after":7162821,"source":{"system":"sec-edgar","filing":"0001193125-26-245341","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526245341/ownership.xml","form_type":"4"}},{"id":779368,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-14T21:33:05.000Z","date":"2026-05-14","kind":"purchase","planned":false,"acquired":true,"shares":61750,"price":2.6153,"value":161494.775,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $2.4950 to $2.8000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 542,784 restricted stock units"}],"balance_after":7158313,"source":{"system":"sec-edgar","filing":"0001193125-26-224391","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526224391/ownership.xml","form_type":"4"}},{"id":779367,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-14T21:33:05.000Z","date":"2026-05-13","kind":"purchase","planned":false,"acquired":true,"shares":49013,"price":2.4592,"value":120532.7696,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $2.3850 to $2.5000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 542,784 restricted stock units"}],"balance_after":7096563,"source":{"system":"sec-edgar","filing":"0001193125-26-224391","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526224391/ownership.xml","form_type":"4"}},{"id":779366,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-14T21:33:05.000Z","date":"2026-05-12","kind":"purchase","planned":false,"acquired":true,"shares":43000,"price":2.1739,"value":93477.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $1.9100 to $2.2800 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 542,784 restricted stock units"}],"balance_after":7047550,"source":{"system":"sec-edgar","filing":"0001193125-26-224391","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526224391/ownership.xml","form_type":"4"}},{"id":848887,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-12T01:00:04.000Z","date":"2026-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":5021,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 542,784 restricted stock units."}],"balance_after":7004550,"source":{"system":"sec-edgar","filing":"0001193125-26-102762","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526102762/ownership.xml","form_type":"4"}},{"id":848886,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-12T01:00:04.000Z","date":"2026-03-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":2062,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 563,403 restricted stock units."}],"balance_after":7009571,"source":{"system":"sec-edgar","filing":"0001193125-26-102762","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526102762/ownership.xml","form_type":"4"}},{"id":932447,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-24T02:30:03.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 22, 2027 and the last installment vesting on January 22, 2030; subject to Reporting Person's providing continued service to Issuer through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 571,871 restricted stock units."}],"balance_after":7011633,"source":{"system":"sec-edgar","filing":"0001193125-26-021449","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526021449/ownership.xml","form_type":"4"}},{"id":932446,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-24T02:30:03.000Z","date":"2026-01-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":14254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 321,871 restricted stock units."}],"balance_after":6761633,"source":{"system":"sec-edgar","filing":"0001193125-26-021449","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526021449/ownership.xml","form_type":"4"}},{"id":940142,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-14T02:30:03.000Z","date":"2026-01-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":13219,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 363,867 restricted stock units."}],"balance_after":6775887,"source":{"system":"sec-edgar","filing":"0001193125-26-012080","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000119312526012080/ownership.xml","form_type":"4"}},{"id":1212508,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-03-12T01:00:13.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":5021,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 408,448 restricted stock units"}],"balance_after":6789106,"source":{"system":"sec-edgar","filing":"0000950170-25-037574","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000095017025037574/ownership.xml","form_type":"4"}},{"id":1212507,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-03-12T01:00:13.000Z","date":"2025-03-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":2063,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 429,067 restricted stock units"}],"balance_after":6794127,"source":{"system":"sec-edgar","filing":"0000950170-25-037574","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000095017025037574/ownership.xml","form_type":"4"}},{"id":1229359,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-03-04T23:30:03.000Z","date":"2025-03-04","kind":"purchase","planned":false,"acquired":true,"shares":60000,"price":8.7344,"value":524064.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $8.3150 to $8.9400 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 437,536 restricted stock units"}],"balance_after":6796190,"source":{"system":"sec-edgar","filing":"0000950170-25-032626","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000095017025032626/ownership.xml","form_type":"4"}},{"id":1295675,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-25T02:30:04.000Z","date":"2025-01-22","kind":"grant","planned":false,"acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 22, 2026 and the last installment vesting on January 22, 2029; subject to Reporting Person's providing continued service to Issuer through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 437,536 restricted stock units"}],"balance_after":6736190,"source":{"system":"sec-edgar","filing":"0000950170-25-008971","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000095017025008971/ownership.xml","form_type":"4"}},{"id":1303568,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-15T02:30:04.000Z","date":"2025-01-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":11905,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 151,882 restricted stock units"}],"balance_after":6511190,"source":{"system":"sec-edgar","filing":"0000950170-25-005577","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000095017025005577/ownership.xml","form_type":"4"}},{"id":1405330,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-09-17T21:17:19.000Z","date":"2024-09-16","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":5.3126,"value":265630.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $5.0550 to $5.5000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 196,464 restricted stock units"}],"balance_after":6523095,"source":{"system":"sec-edgar","filing":"0000950170-24-107401","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000095017024107401/ownership.xml","form_type":"4"}},{"id":1432660,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-08-15T21:30:02.000Z","date":"2024-08-14","kind":"purchase","planned":false,"acquired":true,"shares":85000,"price":6.0037,"value":510314.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $5.9500 to $6.0700 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 196,464 restricted stock units"}],"balance_after":6473095,"source":{"system":"sec-edgar","filing":"0000950170-24-097694","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000095017024097694/ownership.xml","form_type":"4"}},{"id":1483692,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-06-11T21:30:03.000Z","date":"2024-06-11","kind":"purchase","planned":false,"acquired":true,"shares":45000,"price":5.88,"value":264600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $5.6800 to $5.9100 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 196,464 restricted stock units"}],"balance_after":6388095,"source":{"system":"sec-edgar","filing":"0000950170-24-072078","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000095017024072078/ownership.xml","form_type":"4"}},{"id":1509132,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-05-20T20:30:11.000Z","date":"2024-05-17","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":5.5617,"value":556170.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $5.3943 to $5.7480 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 196,464 restricted stock units"}],"balance_after":6343095,"source":{"system":"sec-edgar","filing":"0000950170-24-062435","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000095017024062435/ownership.xml","form_type":"4"}},{"id":1517688,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-05-14T22:19:20.000Z","date":"2024-05-14","kind":"purchase","planned":false,"acquired":true,"shares":150000,"price":5.1187,"value":767805.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.9800 to $5.3500 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 196,646  restricted stock units"}],"balance_after":6243095,"source":{"system":"sec-edgar","filing":"0000950170-24-059854","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000095017024059854/ownership.xml","form_type":"4"}},{"id":1519192,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-05-13T22:07:34.000Z","date":"2024-05-13","kind":"purchase","planned":false,"acquired":true,"shares":150000,"price":4.5566,"value":683490.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.3900 to $4.6400 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 196,646  restricted stock units"}],"balance_after":6093095,"source":{"system":"sec-edgar","filing":"0000950170-24-058878","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000095017024058878/ownership.xml","form_type":"4"}},{"id":1519191,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-05-13T22:07:34.000Z","date":"2024-05-10","kind":"purchase","planned":false,"acquired":true,"shares":150000,"price":4.5792,"value":686880.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.4700 to $4.7500 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 196,646  restricted stock units"}],"balance_after":5943095,"source":{"system":"sec-edgar","filing":"0000950170-24-058878","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000095017024058878/ownership.xml","form_type":"4"}},{"id":1581546,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-13T01:55:06.000Z","date":"2024-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":5021,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 196,646 restricted stock units"}],"balance_after":5793095,"source":{"system":"sec-edgar","filing":"0000950170-24-030472","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000095017024030472/ownership.xml","form_type":"4"}},{"id":1581545,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-13T01:55:06.000Z","date":"2024-03-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":2064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 201,667 restricted stock units"}],"balance_after":5798116,"source":{"system":"sec-edgar","filing":"0000950170-24-030472","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000095017024030472/ownership.xml","form_type":"4"}},{"id":1680130,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Offer"}}],"security":"Common Stock","published_at":"2024-01-13T02:00:14.000Z","date":"2024-01-10","kind":"grant","planned":false,"acquired":true,"shares":178325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each\nRSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 10, 2025 with the last installment vesting on January 10, 2028; subject to Reporting Person's providing continued service to Issuer through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 203,731 restricted stock units."}],"balance_after":5800180,"source":{"system":"sec-edgar","filing":"0001209191-24-001590","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000120919124001590/doc4.xml","form_type":"4"}},{"id":1959013,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Offer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-11T02:00:26.000Z","date":"2023-03-10","kind":"grant","acquired":true,"shares":186900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The stock option will vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027;\nsubject to Reporting Person's providing continued service to Issuer through each vesting date."}],"balance_after":186900,"derivative":{"exercise_price":24.07,"expiration_date":"2033-03-10","underlying":"Stock Option (Right to Buy)","underlying_shares":186900},"source":{"system":"sec-edgar","filing":"0001209191-23-018046","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000120919123018046/doc4.xml","form_type":"4"}},{"id":1959012,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Offer"}}],"security":"Common Stock","published_at":"2023-03-11T02:00:26.000Z","date":"2023-03-10","kind":"grant","acquired":true,"shares":82475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each\nRSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March\n10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 107,881 RSUs."}],"balance_after":5621855,"source":{"system":"sec-edgar","filing":"0001209191-23-018046","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000120919123018046/doc4.xml","form_type":"4"}},{"id":1959011,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Offer"}}],"security":"Common Stock","published_at":"2023-03-11T02:00:26.000Z","date":"2023-03-09","kind":"sale","acquired":false,"shares":2075,"price":24.41,"value":50650.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the\nvesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not\nrepresent a discretionary transaction by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 25,406 restricted stock units."}],"balance_after":5539380,"source":{"system":"sec-edgar","filing":"0001209191-23-018046","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000120919123018046/doc4.xml","form_type":"4"}},{"id":2108798,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Offer"}}],"security":"Common Stock","published_at":"2022-11-21T23:27:07.000Z","date":"2022-11-21","kind":"purchase","acquired":true,"shares":15000,"price":21.827,"value":327405.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $21.5500 to $21.9700 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 33,875 restricted stock units."}],"balance_after":5541455,"source":{"system":"sec-edgar","filing":"0001209191-22-058266","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000120919122058266/doc4.xml","form_type":"4"}},{"id":2112443,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Offer"}}],"security":"Common Stock","published_at":"2022-11-17T22:55:16.000Z","date":"2022-11-17","kind":"purchase","acquired":true,"shares":10000,"price":21.6714,"value":216714.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $21.5450 to $21.7300 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 33,875 restricted stock units."}],"balance_after":5526455,"source":{"system":"sec-edgar","filing":"0001209191-22-057654","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000120919122057654/doc4.xml","form_type":"4"}},{"id":2169101,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Offer"}}],"security":"Common Stock","published_at":"2022-09-01T21:21:17.000Z","date":"2022-09-01","kind":"purchase","acquired":true,"shares":10000,"price":19.8031,"value":198031.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $19.6650 to $19.8900 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 33,875 restricted stock units."}],"balance_after":5516455,"source":{"system":"sec-edgar","filing":"0001209191-22-048290","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000120919122048290/doc4.xml","form_type":"4"}},{"id":2172032,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Offer"}}],"security":"Common Stock","published_at":"2022-08-29T13:00:21.000Z","date":"2022-08-26","kind":"purchase","acquired":true,"shares":21491,"price":20.9549,"value":450341.7559,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $20.9000 to $20.9600 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 33,875 restricted stock units."}],"balance_after":5506455,"source":{"system":"sec-edgar","filing":"0001209191-22-047786","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000120919122047786/doc4.xml","form_type":"4"}},{"id":2175125,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Offer"}}],"security":"Common Stock","published_at":"2022-08-24T23:23:47.000Z","date":"2022-08-24","kind":"purchase","acquired":true,"shares":509,"price":18.9232,"value":9631.9088,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $18.88 to $18.99 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 33,875 restricted stock units."}],"balance_after":5484964,"source":{"system":"sec-edgar","filing":"0001209191-22-047407","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000120919122047407/doc4.xml","form_type":"4"}},{"id":2175124,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Offer"}}],"security":"Common Stock","published_at":"2022-08-24T23:23:47.000Z","date":"2022-08-23","kind":"purchase","acquired":true,"shares":28000,"price":18.7187,"value":524123.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $18.28 to $19.01 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 33,875 restricted stock units."}],"balance_after":5484455,"source":{"system":"sec-edgar","filing":"0001209191-22-047407","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000120919122047407/doc4.xml","form_type":"4"}},{"id":2340059,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-11T01:24:32.000Z","date":"2022-03-08","kind":"grant","acquired":true,"shares":20884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option will vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026; subject to Reporting Person's providing continued service to Issuer through each vesting date."}],"balance_after":20884,"derivative":{"exercise_price":21.065,"expiration_date":"2027-03-08","underlying":"Common Stock","underlying_shares":20884},"source":{"system":"sec-edgar","filing":"0001567619-22-006730","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000156761922006730/doc1.xml","form_type":"4"}},{"id":2340058,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-11T01:24:32.000Z","date":"2022-03-08","kind":"grant","acquired":true,"shares":240566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option will vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026; subject to Reporting Person's providing continued service to Issuer through each vesting date."}],"balance_after":240566,"derivative":{"exercise_price":19.15,"expiration_date":"2032-03-08","underlying":"Common Stock","underlying_shares":240566},"source":{"system":"sec-edgar","filing":"0001567619-22-006730","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000156761922006730/doc1.xml","form_type":"4"}},{"id":2340057,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-03-11T01:24:32.000Z","date":"2022-03-08","kind":"grant","acquired":true,"shares":33875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026? subject to Reporting Person's providing continued service to Issuer through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes  33,875 RSUs."}],"balance_after":5456455,"source":{"system":"sec-edgar","filing":"0001567619-22-006730","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000156761922006730/doc1.xml","form_type":"4"}},{"id":2456293,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-30T23:01:28.000Z","date":"2021-12-29","kind":"sale","acquired":false,"shares":3075,"price":17.013,"value":52314.975,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.00 to $ $17.06 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5422580,"source":{"system":"sec-edgar","filing":"0001567619-21-022717","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000156761921022717/doc1.xml","form_type":"4"}},{"id":2456292,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-30T23:01:28.000Z","date":"2021-12-28","kind":"sale","acquired":false,"shares":19760,"price":16.9941,"value":335803.416,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.755 to $17.585 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5425655,"source":{"system":"sec-edgar","filing":"0001567619-21-022717","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000156761921022717/doc1.xml","form_type":"4"}},{"id":2458708,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-28T01:10:56.000Z","date":"2021-12-27","kind":"sale","acquired":false,"shares":17165,"price":17.4409,"value":299373.0485,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.25 to $17.61 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5445415,"source":{"system":"sec-edgar","filing":"0001567619-21-022542","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000156761921022542/doc1.xml","form_type":"4"}},{"id":2458707,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-28T01:10:56.000Z","date":"2021-12-23","kind":"sale","acquired":false,"shares":22795,"price":16.9573,"value":386541.6535,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.50 to $ $17.29 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5462580,"source":{"system":"sec-edgar","filing":"0001567619-21-022542","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000156761921022542/doc1.xml","form_type":"4"}},{"id":2458706,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-28T01:10:56.000Z","date":"2021-12-22","kind":"sale","acquired":false,"shares":41710,"price":16.2876,"value":679355.796,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.59 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5485375,"source":{"system":"sec-edgar","filing":"0001567619-21-022542","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000156761921022542/doc1.xml","form_type":"4"}},{"id":2461312,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-23T00:05:11.000Z","date":"2021-12-21","kind":"sale","acquired":false,"shares":3537,"price":16.3681,"value":57893.9697,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.32 to $16.45 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5527085,"source":{"system":"sec-edgar","filing":"0001567619-21-022460","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000156761921022460/doc1.xml","form_type":"4"}},{"id":2461311,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-23T00:05:11.000Z","date":"2021-12-21","kind":"sale","acquired":false,"shares":34047,"price":16.0851,"value":547649.3997,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.32 to $16.31 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5530622,"source":{"system":"sec-edgar","filing":"0001567619-21-022460","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000156761921022460/doc1.xml","form_type":"4"}},{"id":2461310,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-23T00:05:11.000Z","date":"2021-12-20","kind":"sale","acquired":false,"shares":600,"price":16.3067,"value":9784.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.24 to $16.32 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5564669,"source":{"system":"sec-edgar","filing":"0001567619-21-022460","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000156761921022460/doc1.xml","form_type":"4"}},{"id":2461309,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-23T00:05:11.000Z","date":"2021-12-20","kind":"sale","acquired":false,"shares":22311,"price":15.7372,"value":351112.6692,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.205 to $15.935 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5565269,"source":{"system":"sec-edgar","filing":"0001567619-21-022460","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000156761921022460/doc1.xml","form_type":"4"}},{"id":2495701,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-25T01:48:24.000Z","date":"2021-11-24","kind":"sale","acquired":false,"shares":30257,"price":17.9985,"value":544580.6145,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.94 to $18.09 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon\nrequest, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5587580,"source":{"system":"sec-edgar","filing":"0001567619-21-021184","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000156761921021184/doc1.xml","form_type":"4"}},{"id":2495700,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-25T01:48:24.000Z","date":"2021-11-24","kind":"sale","acquired":false,"shares":25743,"price":17.6632,"value":454703.7576,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.94 to $17.93 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon\nrequest, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5617837,"source":{"system":"sec-edgar","filing":"0001567619-21-021184","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000156761921021184/doc1.xml","form_type":"4"}},{"id":2495699,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-25T01:48:24.000Z","date":"2021-11-23","kind":"sale","acquired":false,"shares":2725,"price":18,"value":49050.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.21 to $18.47 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon\nrequest, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5643580,"source":{"system":"sec-edgar","filing":"0001567619-21-021184","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000156761921021184/doc1.xml","form_type":"4"}},{"id":2495698,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-25T01:48:24.000Z","date":"2021-11-23","kind":"sale","acquired":false,"shares":53275,"price":17.3747,"value":925637.1425,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.14 to $17.66 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon\nrequest, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5646305,"source":{"system":"sec-edgar","filing":"0001567619-21-021184","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000156761921021184/doc1.xml","form_type":"4"}},{"id":2495697,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-25T01:48:24.000Z","date":"2021-11-22","kind":"sale","acquired":false,"shares":646,"price":19.11,"value":12345.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.02 to $19.54 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon\nrequest, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5699580,"source":{"system":"sec-edgar","filing":"0001567619-21-021184","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000156761921021184/doc1.xml","form_type":"4"}},{"id":2495696,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-25T01:48:24.000Z","date":"2021-11-22","kind":"sale","acquired":false,"shares":52354,"price":18.34,"value":960172.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.01 to $19.00\ninclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon\nrequest, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5700226,"source":{"system":"sec-edgar","filing":"0001567619-21-021184","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000156761921021184/doc1.xml","form_type":"4"}},{"id":2536556,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-23T01:36:35.000Z","date":"2021-09-07","kind":"grant","acquired":true,"shares":408816,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"As Co-Trustee of the John R. Treace Irrevocable Trust dated July 29, 2021"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as Trustee or Co-Trustee."}],"balance_after":408816,"source":{"system":"sec-edgar","filing":"0001567619-21-018627","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000156761921018627/doc1.xml","form_type":"4"}},{"id":2536555,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-23T01:36:35.000Z","date":"2021-10-22","kind":"sale","acquired":false,"shares":555,"price":21.1578,"value":11742.579,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $21.14 to $21.21 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon\nrequest, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5752580,"source":{"system":"sec-edgar","filing":"0001567619-21-018627","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000156761921018627/doc1.xml","form_type":"4"}},{"id":2536554,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-23T01:36:35.000Z","date":"2021-10-22","kind":"sale","acquired":false,"shares":57534,"price":20.7397,"value":1193237.8998,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.12 to $21.03 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon\nrequest, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5753135,"source":{"system":"sec-edgar","filing":"0001567619-21-018627","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000156761921018627/doc1.xml","form_type":"4"}},{"id":2536553,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-23T01:36:35.000Z","date":"2021-10-21","kind":"sale","acquired":false,"shares":39,"price":24.5,"value":955.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":5810669,"source":{"system":"sec-edgar","filing":"0001567619-21-018627","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000156761921018627/doc1.xml","form_type":"4"}},{"id":2536552,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-23T01:36:35.000Z","date":"2021-10-21","kind":"sale","acquired":false,"shares":4044,"price":23.8552,"value":96470.4288,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.38 to $24.25 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon\nrequest, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5810708,"source":{"system":"sec-edgar","filing":"0001567619-21-018627","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000156761921018627/doc1.xml","form_type":"4"}},{"id":2536551,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-23T01:36:35.000Z","date":"2021-10-21","kind":"sale","acquired":false,"shares":8207,"price":23.0705,"value":189339.5935,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.37 to $23.36 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon\nrequest, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5814752,"source":{"system":"sec-edgar","filing":"0001567619-21-018627","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000156761921018627/doc1.xml","form_type":"4"}},{"id":2536550,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-23T01:36:35.000Z","date":"2021-10-21","kind":"sale","acquired":false,"shares":2768,"price":21.4949,"value":59497.8832,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $21.30 to $21.98 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon\nrequest, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5822959,"source":{"system":"sec-edgar","filing":"0001567619-21-018627","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000156761921018627/doc1.xml","form_type":"4"}},{"id":2536549,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-23T01:36:35.000Z","date":"2021-10-21","kind":"sale","acquired":false,"shares":26701,"price":20.6733,"value":551997.7833,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.22 to $21.16 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon\nrequest, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5825727,"source":{"system":"sec-edgar","filing":"0001567619-21-018627","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000156761921018627/doc1.xml","form_type":"4"}},{"id":2536548,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-23T01:36:35.000Z","date":"2021-10-21","kind":"sale","acquired":false,"shares":34325,"price":19.894,"value":682861.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.21 to $20.21 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon\nrequest, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5852428,"source":{"system":"sec-edgar","filing":"0001567619-21-018627","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000156761921018627/doc1.xml","form_type":"4"}},{"id":2536547,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-23T01:36:35.000Z","date":"2021-10-20","kind":"sale","acquired":false,"shares":8215,"price":25.3654,"value":208376.761,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.22 to $25.69 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon\nrequest, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5886753,"source":{"system":"sec-edgar","filing":"0001567619-21-018627","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000156761921018627/doc1.xml","form_type":"4"}},{"id":2536546,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-23T01:36:35.000Z","date":"2021-10-20","kind":"sale","acquired":false,"shares":22612,"price":24.7891,"value":560531.1292,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $24.21 to $25.21 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon\nrequest, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5894968,"source":{"system":"sec-edgar","filing":"0001567619-21-018627","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000156761921018627/doc1.xml","form_type":"4"}},{"id":2736049,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series A Preferred Stock","published_at":"2021-04-30T01:20:23.000Z","date":"2021-04-27","kind":"exercise","acquired":false,"shares":299510,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":299510},"source":{"system":"sec-edgar","filing":"0000899243-21-017486","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000089924321017486/doc4.xml","form_type":"4"}},{"id":2736048,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series A Preferred Stock","published_at":"2021-04-30T01:20:23.000Z","date":"2021-04-27","kind":"other","acquired":true,"shares":6932,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend."}],"balance_after":299510,"derivative":{"underlying":"Common Stock","underlying_shares":6932},"source":{"system":"sec-edgar","filing":"0000899243-21-017486","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000089924321017486/doc4.xml","form_type":"4"}},{"id":2736047,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-04-30T01:20:23.000Z","date":"2021-04-27","kind":"sale","acquired":false,"shares":5253805,"price":17,"value":89314685.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were sold by the Reporting Person as a selling stockholder in conjuction with the Issuer's Form S-1 filing, Registration Number 333-254863. The offering closed on April 27, 2021. The reported sale price reflects the price at which the Reporting Person sold shares to the underwriters."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were sold by the Reporting Person as a selling stockholder in conjuction with the Issuer's Form S-1 filing, Registration Number 333-254863. The offering closed on April 27, 2021. The reported sale price reflects the price at which the Reporting Person sold shares to the underwriters."}],"balance_after":5917580,"source":{"system":"sec-edgar","filing":"0000899243-21-017486","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000089924321017486/doc4.xml","form_type":"4"}},{"id":2736046,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":20402,"kind":"person","name":"Treace John T.","position":1,"cik":"0001856380","reported_name":"Treace John T.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-04-30T01:20:23.000Z","date":"2021-04-27","kind":"exercise","acquired":true,"shares":299510,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."}],"balance_after":11171385,"source":{"system":"sec-edgar","filing":"0000899243-21-017486","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856380/000089924321017486/doc4.xml","form_type":"4"}}]}